rxstat › Classes › Angiotensin Ii Antagonists, Plain

Angiotensin Ii Antagonists, Plain: shortage status in Canada

6 of the 7 angiotensin ii antagonists, plain rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.

Candesartan Cilexetil (Atacand) Partial shortage 21 of 59 reported products affected · est. return Aug 14, 2026 Irbesartan (Avapro) Partial shortage 10 of 43 reported products affected Losartan (Cozaar) Partial shortage 16 of 45 reported products affected · est. return Dec 31, 2026 Olmesartan Medoxomil (Olmetec) Partial shortage 2 of 24 reported products affected Telmisartan (Micardis) Partial shortage 3 of 26 reported products affected Valsartan (Diovan) Partial shortage 3 of 43 reported products affected · est. return Aug 14, 2026 Azilsartan Medoxomil (Edarbi) No current shortage

Guides: what to do when your medication is in shortage · how to read these statuses

Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.